These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34286555)

  • 1. The new patterns of nephrolithiasis: What has been changing in the last millennium?
    Cicerello E; Ciaccia M; Cova GD; Mangano MS
    Arch Ital Urol Androl; 2021 Jun; 93(2):195-199. PubMed ID: 34286555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrolithiasis and loss of kidney function.
    Keddis MT; Rule AD
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):390-6. PubMed ID: 23736840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of being overweight on urinary metabolic risk factors for kidney stone formation.
    Shavit L; Ferraro PM; Johri N; Robertson W; Walsh SB; Moochhala S; Unwin R
    Nephrol Dial Transplant; 2015 Apr; 30(4):607-13. PubMed ID: 25362001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.
    Dhondup T; Kittanamongkolchai W; Vaughan LE; Mehta RA; Chhina JK; Enders FT; Hickson LJ; Lieske JC; Rule AD
    Am J Kidney Dis; 2018 Dec; 72(6):790-797. PubMed ID: 30146423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Am J Kidney Dis; 2004 Nov; 44(5):799-805. PubMed ID: 15492945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and urolithiasis: evidence of regional influences.
    Trinchieri A; Croppi E; Montanari E
    Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of BMI in nephrolithiasis in an Appalachian pediatric population: A single-center experience.
    Murphy MO; Erpelding SG; Chishti AS; Dugan A; Ziada A; Kiessling SG
    J Pediatr Urol; 2018 Aug; 14(4):330.e1-330.e8. PubMed ID: 29887297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Syndrome and Kidney Stone Disease: A Systematic Review of Literature.
    Wong Y; Cook P; Roderick P; Somani BK
    J Endourol; 2016 Mar; 30(3):246-53. PubMed ID: 26576717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for urolithiasis].
    Mohebbi N
    Ther Umsch; 2021 Jun; 78(5):223-227. PubMed ID: 34032133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and metabolic stone disease.
    Wollin DA; Skolarikos A; Preminger GM
    Curr Opin Urol; 2017 Sep; 27(5):422-427. PubMed ID: 28650866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and kidney stone disease: a systematic review.
    Carbone A; Al Salhi Y; Tasca A; Palleschi G; Fuschi A; De Nunzio C; Bozzini G; Mazzaferro S; Pastore AL
    Minerva Urol Nefrol; 2018 Aug; 70(4):393-400. PubMed ID: 29856171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic diagnosis in stone formers in relation to body mass index.
    Del Valle EE; Negri AL; Spivacow FR; Rosende G; Forrester M; Pinduli I
    Urol Res; 2012 Feb; 40(1):47-52. PubMed ID: 21660441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characteristics of genetic disease in adult kidney stone formers.
    Anderegg MA; Olinger EG; Bargagli M; Geraghty R; Taylor L; Nater A; Bruggmann R; Sayer JA; Vogt B; Schaller A; Fuster DG
    Nephrol Dial Transplant; 2024 Aug; 39(9):1426-1441. PubMed ID: 38544324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrolithiasis-induced ESRD: frequency, causes and prevention].
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Nephrol Ther; 2005 Nov; 1(5):301-10. PubMed ID: 16895699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome: a multifaceted risk factor for kidney stones.
    Domingos F; Serra A
    Scand J Urol; 2014 Oct; 48(5):414-9. PubMed ID: 24708398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.
    Sakhaee K; Maalouf NM; Sinnott B
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1847-60. PubMed ID: 22466339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
    Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
    Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid nephrolithiasis: An update.
    Cicerello E
    Urologia; 2018 Aug; 85(3):93-98. PubMed ID: 29687761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.